Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 27, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2025
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint Blockade.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 28, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 19, 2023
CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone.
Journal: JCO precision oncology
Published: July 12, 2022
Novel Therapeutics in the Treatment of Uterine Sarcoma.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 17, 2022
Glucose Metabolism in Cancer: The Warburg Effect and Beyond.
Journal: Advances in experimental medicine and biology
Published: May 20, 2021
Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: June 16, 2020
Glucose Metabolism in Cancer.
Journal: Advances in experimental medicine and biology
Published: June 28, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026